PP
ONCE

PDT Partners’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

PDT Partners’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-36,645
Closed -$4.17M – 497
2019
Q1 		$4.17M Sell
36,645
-157,174
-81% -$11.6M 0.24% 127
2018
Q4 		$7.59M Buy
193,819
+16,791
+9% +$728K 0.42% 94
2018
Q3 		$9.66M Sell
177,028
-22,444
-11% -$1.53M 0.4% 77
2018
Q2 		$16.5M Sell
199,472
-13,367
-6% -$1.03M 0.63% 42
2018
Q1 		$14.2M Buy
+212,839
New +$12.3M 0.48% 62

Other funds holding ONCE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

PDT Partners's ONCE Position: Q2 2019 in Review

PDT Partners sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q2 2019, closing a stake of 36,645 shares — an estimated $4.17M sold.

PDT Partners first reported a position in ONCE in Q1 2018 and held it in 5 quarters. The position peaked at $16.5M in Q2 2018. 194 funds tracked by Wall St. Rank hold ONCE as of Q2 2019.

  • PDT Partners reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • PDT Partners sold 36,645 Spark Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $4.17M.
  • PDT Partners first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2018 and held it in 5 quarters.
  • PDT Partners's Spark Therapeutics, Inc. Common Stock position peaked at $16.5M in Q2 2018.
  • 194 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q2 2019.

Based on PDT Partners's 13F filing for Q2 2019, filed 14 Aug 2019.